Alopecia differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 20: | Line 20: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Androgenetic Alopecia <ref name="pmid24591533">{{cite journal| author=Qi J, Garza LA| title=An overview of alopecias. | journal=Cold Spring Harb Perspect Med | year= 2014 | volume= 4 | issue= 3 | pages= | pmid=24591533 | doi=10.1101/cshperspect.a013615 | pmc=3935391 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24591533 }} </ref> <ref name="pmid30513014">{{cite journal| author=Rinaldi F, Marzani B, Pinto D, Sorbellini E| title=Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata. | journal=J Dermatolog Treat | year= 2019 | volume= 30 | issue= 6 | pages= 588-593 | pmid=30513014 | doi=10.1080/09546634.2018.1544405 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30513014 }} </ref> <ref name="pmid26455063">{{cite journal| author=Vidal CI| title=Overview of Alopecia: A Dermatopathologist's Perspective. | journal=Mo Med | year= 2015 | volume= 112 | issue= 4 | pages= 308-12 | pmid=26455063 | doi= | pmc=6170065 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26455063 }} </ref> | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Androgenetic Alopecia <ref name="pmid24591533">{{cite journal| author=Qi J, Garza LA| title=An overview of alopecias. | journal=Cold Spring Harb Perspect Med | year= 2014 | volume= 4 | issue= 3 | pages= | pmid=24591533 | doi=10.1101/cshperspect.a013615 | pmc=3935391 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24591533 }} </ref> <ref name="pmid30513014">{{cite journal| author=Rinaldi F, Marzani B, Pinto D, Sorbellini E| title=Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata. | journal=J Dermatolog Treat | year= 2019 | volume= 30 | issue= 6 | pages= 588-593 | pmid=30513014 | doi=10.1080/09546634.2018.1544405 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30513014 }} </ref> <ref name="pmid26455063">{{cite journal| author=Vidal CI| title=Overview of Alopecia: A Dermatopathologist's Perspective. | journal=Mo Med | year= 2015 | volume= 112 | issue= 4 | pages= 308-12 | pmid=26455063 | doi= | pmc=6170065 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26455063 }} </ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Male pattern: The frontal hairline is thinner, hair loss occurs at the crown of the scalp, hair recession is seen at the temporal aspects of the scalp; Female pattern: Hair loss occurs at the crown of the scalp, however the frontal | * Male pattern: The frontal hairline is thinner, hair loss occurs at the crown of the scalp, hair recession is seen at the temporal aspects of the scalp; Female pattern: Hair loss occurs at the crown of the scalp, however, the frontal hairline remains preserved. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Androgenetic alopecia]] is believed to have a worldwide [[prevalence]] of about 50,000 per 100,000 men and 15,000 per 100,000 women with post-menopausal women making up the majority. | * [[Androgenetic alopecia]] is believed to have a worldwide [[prevalence]] of about 50,000 per 100,000 men and 15,000 per 100,000 women with post-menopausal women making up the majority. | ||
Line 50: | Line 50: | ||
* It may be chronic and present in association with female pattern hair loss. | * It may be chronic and present in association with female pattern hair loss. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Anagen Effluvium | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Anagen Effluvium <ref name="pmid24591533">{{cite journal| author=Qi J, Garza LA| title=An overview of alopecias. | journal=Cold Spring Harb Perspect Med | year= 2014 | volume= 4 | issue= 3 | pages= | pmid=24591533 | doi=10.1101/cshperspect.a013615 | pmc=3935391 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24591533 }} </ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* There is diffuse hair loss and it is characterized by hair breakage that takes place in the anagen phase. | * There is diffuse hair loss and it is characterized by hair breakage that takes place in the anagen phase. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Associated with exposure to radiation, as in radiotherapy and cancer chemotherapy. | * Associated with exposure to radiation, as in radiotherapy and cancer chemotherapy. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Trichoscopy would reveal the characteristic narrowing, fractured hair shafts with an absence of bulbs. | * Trichoscopy would reveal the characteristic narrowing, fractured hair shafts with an absence of bulbs. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
- | - | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Trichotillomania | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Trichotillomania <ref>Sperling LC, Cowper SE, Knopp EA. An atlas of hair pathology with clinical correlations. 2. Informa Healthcare; 2014. [Google Scholar]</ref> <ref name="pmid1938977">{{cite journal| author=Christenson GA, Pyle RL, Mitchell JE| title=Estimated lifetime prevalence of trichotillomania in college students. | journal=J Clin Psychiatry | year= 1991 | volume= 52 | issue= 10 | pages= 415-7 | pmid=1938977 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1938977 }} </ref> <ref name="pmid7559316">{{cite journal| author=King RA, Zohar AH, Ratzoni G, Binder M, Kron S, Dycian A | display-authors=etal| title=An epidemiological study of [[trichotillomania]] in Israeli adolescents. | journal=J Am Acad Child Adolesc Psychiatry | year= 1995 | volume= 34 | issue= 9 | pages= 1212-5 | pmid=7559316 | doi=10.1097/00004583-199509000-00019 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7559316 }} </ref> <ref name="pmid19926375">{{cite journal| author=Duke DC, Keeley ML, Geffken GR, Storch EA| title=Trichotillomania: A current review. | journal=Clin Psychol Rev | year= 2010 | volume= 30 | issue= 2 | pages= 181-93 | pmid=19926375 | doi=10.1016/j.cpr.2009.10.008 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19926375 }} </ref> <ref name="pmid20946585">{{cite journal| author=Quercetani R, Rebora AE, Fedi MC, Carelli G, Mei S, Chelli A | display-authors=etal| title=Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita. | journal=J Eur Acad Dermatol Venereol | year= 2011 | volume= 25 | issue= 7 | pages= 808-10 | pmid=20946585 | doi=10.1111/j.1468-3083.2010.03869.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20946585 }} </ref> <ref name="pmid24591533">{{cite journal| author=Qi J, Garza LA| title=An overview of alopecias. | journal=Cold Spring Harb Perspect Med | year= 2014 | volume= 4 | issue= 3 | pages= | pmid=24591533 | doi=10.1101/cshperspect.a013615 | pmc=3935391 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24591533 }} </ref> <ref>Habif TP 2010. Hair diseases. In Clinical dermatology, 5th ed Mosby, Maryland Heights, MO [Google Scholar]</ref> <ref>Otberg N, Shapiro J 2012. Hair growth disorders. In Fitzpatrick’s dermatology in general medicine, 8th ed (ed. Goldsmith LA, et al.). McGraw-Hill, New York [Google Scholar]</ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Presents with uneven broken hairs in the most frequently selected areas which are the scalp, eyebrows, eyelashes, body hair, facial hair, and pubic hair. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Based on the limited studies that have been done to determine the [[prevalence]] of [[trichotillomania]] among U.S. university students, Israeli adolescents, and older adults within the same community, the prevalence was shown to be between 500 per 100,000 to 2000 per 100,000. | ||
* It usually starts around the age of 12–13 years | |||
* It is more common in males during the childhood years while it is more common in females in the adult years. | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Scalp inspection reveals uneven patches of hair loss with broken hairs that remain well attached to the skin. | |||
* A characteristic finding that distinguishes trichotillomania from alopecia areata is that the affected areas are not totally devoid of hair shafts. | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* It occurs as a result of a lack of impulse control in which an individual pulls on hair. | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Traction Alopecia | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Traction Alopecia <ref>Otberg N, Shapiro J 2012. Hair growth disorders. In Fitzpatrick’s dermatology in general medicine, 8th ed (ed. Goldsmith LA, et al.). McGraw-Hill, New York [Google Scholar]</ref> <ref name="pmid24591533">{{cite journal| author=Qi J, Garza LA| title=An overview of alopecias. | journal=Cold Spring Harb Perspect Med | year= 2014 | volume= 4 | issue= 3 | pages= | pmid=24591533 | doi=10.1101/cshperspect.a013615 | pmc=3935391 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24591533 }} </ref> <ref name="pmid15113284">{{cite journal| author=Callender VD, McMichael AJ, Cohen GF| title=Medical and surgical therapies for alopecias in black women. | journal=Dermatol Ther | year= 2004 | volume= 17 | issue= 2 | pages= 164-76 | pmid=15113284 | doi=10.1111/j.1396-0296.2004.04017.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15113284 }} </ref> <ref name="pmid29265342">{{cite journal| author=Aguado Lobo M, Jiménez-Reyes J| title=Traction alopecia. | journal=Int J Dermatol | year= 2018 | volume= 57 | issue= 2 | pages= 231-232 | pmid=29265342 | doi=10.1111/ijd.13846 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi? dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29265342 }} </ref> <ref name="pmid15113284">{{cite journal| author=Callender VD, McMichael AJ, Cohen GF| title=Medical and surgical therapies for alopecias in black women. | journal=Dermatol Ther | year= 2004 | volume= 17 | issue= 2 | pages= 164-76 | pmid=15113284 | doi=10.1111/j.1396-0296.2004.04017.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15113284 }} </ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Hair loss at regions of the scalp exposed to tension on hair follicles for a prolonged period of time in people who make tight hairstyles. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * [[Traction alopecia]] is more commonly seen among black populations with females being affected more often than males at a rate of about 31,000-32,000 per 100,000 women compared to about 2,300 per 100,000 men. | ||
* [[Traction alopecia]] is seen in about 18,000 per 100,000 girls between the ages of 5.4 to 14.3 years based on a study of African-American girls. | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Mostly a clinical diagnosis based on hair loss at areas of the scalp where tension on the hair is highest. | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Early detection and switching to more loose hairstyles may reverse the condition, however, with prolonged tension on the scalp destruction of the hair follicles will occur, causing the condition to become irreversible. | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Chronic Cutaneous Lupus Erythematosus | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Chronic Cutaneous Lupus Erythematosus <ref>Sperling LC, Cowper SE, Knopp EA. An atlas of hair pathology with clinical correlations. 2. Informa Healthcare; 2014. [Google Scholar]</ref> <ref name="pmid24591533">{{cite journal| author=Qi J, Garza LA| title=An overview of alopecias. | journal=Cold Spring Harb Perspect Med | year= 2014 | volume= 4 | issue= 3 | pages= | pmid=24591533 | doi=10.1101/cshperspect.a013615 | pmc=3935391 | url=https://www.ncbi.nlm.nih.gov/entrg to more loose hairstyles may reverse the hair loss but with prolonged tension on the scalp destruction of the hair follicles will occur making the condition iez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24591533 }} </ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Presents with an area with hair loss that gradually converts into | * Presents with an area with hair loss that gradually converts into scaly, thickened papules then into poorly-defined, variably-shaped plaques with atrophy, follicular plugging, telangiectasia, and depigmentation. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Black populations tend to have more serious disease. | ||
* [[Cutaneous lupus erythematosus]] is more common in males than in females, with a ratio of about 59.4 per 100,000 versus 1.6 per 100,000. | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Histological analysis after a hair pull test reveals a higher anagen count during active disease. | |||
* [[Direct immunofluorescence]] may reveal granular C3 and IgG at the dermo-epidermal boundary which is found in greater than 70% of cases. | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
- | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Tinea Capitis | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Tinea Capitis <ref name="pmid30725594">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume= | issue= | pages= | pmid=30725594 | doi= | pmc= | url= }} </ref> <ref name="pmid12431130">{{cite journal| author=Pomeranz AJ, Sabnis SS| title=Tinea capitis: epidemiology, diagnosis and management strategies. | journal=Paediatr Drugs | year= 2002 | volume= 4 | issue= 12 | pages= 779-83 | pmid=12431130 | doi=10.2165/00128072-200204120-00002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12431130 }} </ref> <ref name="pmid19502982">{{cite journal| author=Kos L, Conlon J| title=An update on alopecia areata. | journal=Curr Opin Pediatr | year= 2009 | volume= 21 | issue= 4 | pages= 475-80 | pmid=19502982 | doi=10.1097/MOP.0b013e32832db986 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19502982 }} </ref> <ref>Sperling LC, Cowper SE, Knopp EA. An atlas of hair pathology with clinical correlations. 2. Informa Healthcare; 2014. [Google Scholar]</ref> <ref name="pmid22972730">{{cite journal| author=Ponka D, Baddar F| title=Wood lamp examination. | journal=Can Fam Physician | year= 2012 | volume= 58 | issue= 9 | pages= 976 | pmid=22972730 | doi= | pmc=3440273 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22972730 }} </ref> <ref name="pmid26455063">{{cite journal| author=Vidal CI| title=Overview of Alopecia: A Dermatopathologist's Perspective. | journal=Mo Med | year= 2015 | volume= 112 | issue= 4 | pages= 308-12 | pmid=26455063 | doi= | pmc=6170065 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26455063 }} </ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Presents in diverse ways such as ordinary scaling without any obvious hair loss which is considered to be a seborrheic form, a crusted or pustular form that may be localized or diffuse, a ‘black dot’ type that is characterized by tiny black dots within regions of alopecia, an inflammatory mass called kerion, and a round, bald, scaly patch where the follicular ostia are filled with keratinous debris. | ||
* A unique feature of tinea capitis is the presence of post-auricular and cervical lymphadenopathy. | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* It is more common in the pediatric population. | * It is more common in the pediatric population. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Potassium hydroxide preparation can be added to skin scrapings of affected areas in order to diagnose the condition. <ref name="pmid24591533">{{cite journal| author=Qi J, Garza LA| title=An overview of alopecias. | journal=Cold Spring Harb Perspect Med | year= 2014 | volume= 4 | issue= 3 | pages= | pmid=24591533 | doi=10.1101/cshperspect.a013615 | pmc=3935391 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24591533 }} </ref> | |||
* Wood's light can also be used in diagnosis as majority of Microsporum spp will appear bluish-green, occasionally dull yellow (Microsporum gypseum) and dull blue (Trichophyton schoenleinii). | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* In the U.S., under 5% of cases will show fluorescence. | |||
* Possible complications of tinea capitis are [[kerion]], an [[abscess]] in the scalp, or [[favus]], another inflammatory form in which there is honeycomb destruction of the hair shaft. Both are severe forms of the disease and can cause permanent scarring. | |||
|} | |} | ||
Line 195: | Line 205: | ||
*[[Sarcoidosis]] | *[[Sarcoidosis]] | ||
*[[Scleroderma]] | *[[Scleroderma]] | ||
*[[Systemic Lupus Erythematosus]] <ref name="pmid32699719">{{cite journal| author=Forouzan P, Cohen PR| title=Systemic Lupus Erythematosus Presenting as Alopecia Areata. | journal=Cureus | year= 2020 | volume= 12 | issue= 6 | pages= e8724 | pmid=32699719 | doi=10.7759/cureus.8724 | pmc=7372242 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom= | *[[Systemic Lupus Erythematosus]] <ref name="pmid32699719">{{cite journal| author=Forouzan P, Cohen PR| title=Systemic Lupus Erythematosus Presenting as Alopecia Areata. | journal=Cureus | year= 2020 | volume= 12 | issue= 6 | pages= e8724 | pmid=32699719 | doi=10.7759/cureus.8724 | pmc=7372242 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmedomyositis. | journal=Lancet | year= 2000 | volume= 355 | issue= 9197 | pages= 53-7 | pmid=10615903 | doi=10.1016/S0140-6736(99)05157-0 | pmc= | url=https://&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32699719 }} </ref>, [[dermatomyositis]] <ref name="pmid10615903">{{cite journal| author=Callen JP| title=Dermatwww.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10615903 }} </ref> | ||
===Miscellaneous=== | ===Miscellaneous=== |
Revision as of 06:51, 2 February 2021
Alopecia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Alopecia differential diagnosis On the Web |
American Roentgen Ray Society Images of Alopecia differential diagnosis |
Risk calculators and risk factors for Alopecia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD
Overview
There is a very wide list of diseases and conditions that can lead to alopecia. Proper history taking and physical examination, along with laboratory, microbiology, and in some cases, imaging studies, are helpful in narrowing down the diagnosis. Alopecia can be caused by many different diseases. Some of the most well known and common causes are: androgenetic alopecia, alopecia areata, telogen effluvium, anagen effluvium, traction alopecia, and trichotillomania. Endocrine disorders such as hypothyroidism, hypoparathyroidism and Cushing's syndrome as well as malnutrition and medications are also possible causes of alopecia.
Differentiating Alopecia from Other diseases
Disease/Condition | Clinical presentation | Demographics/History | Diagnosis | Other notes |
---|---|---|---|---|
Androgenetic Alopecia [1] [2] [3] |
|
|
|
|
Alopecia Areata [1] [4] [5] [6] [3] [7] [8] [9] |
|
|
|
|
Telogen Effluvium [10] [11] [3] |
|
|
|
|
Anagen Effluvium [1] |
|
|
|
- |
Trichotillomania [12] [13] [14] [15] [16] [1] [17] [18] |
|
|
|
|
Traction Alopecia [19] [1] [20] [21] [20] |
|
|
|
|
Chronic Cutaneous Lupus Erythematosus [22] [1] |
|
|
|
- |
Tinea Capitis [23] [24] [25] [26] [27] [3] |
|
|
|
The following lists the complete differential diagnosis of Alopecia:
Non-Scarring Alopecia
- Adrenocortical insufficiency (primary or secondary)
- Anagen effluvium (anagen=growing hair)
- Cushing's syndrome
- Diffuse hair thinning due to metabolic causes
- Hyperthyroidism
- Hypoparathyroidism
- Hypothyroidism
- Pituitary insufficiency
- Secondary syphilis
- Sheehan's syndrome
- Telogen effluvium (telogen=resting hair)
- Temporary hair loss
- Thyroiditis
- Trichotillomania
Scarring Alopecia
- Amyloidosis
- Chronic disciform lupus erythematosis
- Congenital defects
- Discoid Lupus Erythematosus
- Dissecting cellulitis
- Herpes zoster infection
- Infection
- Inflammatory dermatoses
- Lichen planopilaris
- Lymphoma
- Morphea
- Mycosis fungoides
- Neoplasm
- Neurodermatitis
- Physical or chemical agents:
- ACE inhibitors
- Allopurinol
- Androgens
- Anticoagulants [28]
- Anticonvulsants [29] [30]
- Antimycotic agents
- Arsenic
- Azathioprine
- Beta blockers [31]
- Borates
- Cadmium
- Chemotherapeutics
- Chlorambucil
- Cisplatin
- Clofibrate
- Cyclophosphamide
- Cytarabine
- Estrogens
- Fluororacil
- Gentamycin
- Gold compounds
- Heparins
- Indomethacin
- Levodopa
- Linolic acid
- Mercury and derivatives
- Methotrexate
- Niacin
- Oral contraceptives
- Propranolol
- Retinoids
- Salicylates
- Selenium
- Squalenes
- Steroids
- Thallium
- Undecylenic acid
- Vitamin A overdose
- Warfarin
- Pseudofolliculitis barbae
- Psoriasis
- Sarcoidosis
- Scleroderma
- Systemic Lupus Erythematosus [32], dermatomyositis [33]
Miscellaneous
- Addison's Disease
- Anemia
- Cancer
- Diabetes Mellitus
- Pneumonia
- Scarlet Fever
- Schmidt's Syndrome
- Stress
- Testicular feminization syndrome
- Turner's Syndrome
- Typhoid fever
- Mechanical effects
- Traction alopecia
- Pressure alopecia (alopecia after extended bed rest)
- Trichotillomania (compulsion to pull out one’s own hair)
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Qi J, Garza LA (2014). "An overview of alopecias". Cold Spring Harb Perspect Med. 4 (3). doi:10.1101/cshperspect.a013615. PMC 3935391. PMID 24591533.
- ↑ Rinaldi F, Marzani B, Pinto D, Sorbellini E (2019). "Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata". J Dermatolog Treat. 30 (6): 588–593. doi:10.1080/09546634.2018.1544405. PMID 30513014.
- ↑ 3.0 3.1 3.2 3.3 Vidal CI (2015). "Overview of Alopecia: A Dermatopathologist's Perspective". Mo Med. 112 (4): 308–12. PMC 6170065. PMID 26455063.
- ↑ Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM; et al. (2018). "Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis". J Am Acad Dermatol. 78 (1): 1–12. doi:10.1016/j.jaad.2017.04.1141. PMID 29241771.
- ↑ Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ (1995). "Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989". Mayo Clin Proc. 70 (7): 628–33. doi:10.4065/70.7.628. PMID 7791384.
- ↑ Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR (2014). "Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009". J Invest Dermatol. 134 (4): 1141–1142. doi:10.1038/jid.2013.464. PMC 3961558. PMID 24202232.
- ↑ Villasante Fricke AC, Miteva M (2015). "Epidemiology and burden of alopecia areata: a systematic review". Clin Cosmet Investig Dermatol. 8: 397–403. doi:10.2147/CCID.S53985. PMC 4521674. PMID 26244028.
- ↑ Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY; et al. (2011). "Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study". J Am Acad Dermatol. 65 (5): 949–56. doi:10.1016/j.jaad.2010.08.032. PMID 21616562.
- ↑ Chen CH, Wang KH, Lin HC, Chung SD (2016) Follow-up study on the relationship between alopecia areata and risk of autoimmune diseases. J Dermatol 43 (2):228-9. DOI:10.1111/1346-8138.13165 PMID: 26499292
- ↑ Sperling LC, Cowper SE, Knopp EA. An atlas of hair pathology with clinical correlations. 2. Informa Healthcare; 2014. [Google Scholar]
- ↑ Sant'Anna Addor FA, Donato LC, Melo CSA (2018). "Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium". Clin Cosmet Investig Dermatol. 11: 431–436. doi:10.2147/CCID.S173082. PMC 6136400. PMID 30237729.
- ↑ Sperling LC, Cowper SE, Knopp EA. An atlas of hair pathology with clinical correlations. 2. Informa Healthcare; 2014. [Google Scholar]
- ↑ Christenson GA, Pyle RL, Mitchell JE (1991). "Estimated lifetime prevalence of trichotillomania in college students". J Clin Psychiatry. 52 (10): 415–7. PMID 1938977.
- ↑ King RA, Zohar AH, Ratzoni G, Binder M, Kron S, Dycian A; et al. (1995). "An epidemiological study of [[trichotillomania]] in Israeli adolescents". J Am Acad Child Adolesc Psychiatry. 34 (9): 1212–5. doi:10.1097/00004583-199509000-00019. PMID 7559316. URL–wikilink conflict (help)
- ↑ Duke DC, Keeley ML, Geffken GR, Storch EA (2010). "Trichotillomania: A current review". Clin Psychol Rev. 30 (2): 181–93. doi:10.1016/j.cpr.2009.10.008. PMID 19926375.
- ↑ Quercetani R, Rebora AE, Fedi MC, Carelli G, Mei S, Chelli A; et al. (2011). "Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita". J Eur Acad Dermatol Venereol. 25 (7): 808–10. doi:10.1111/j.1468-3083.2010.03869.x. PMID 20946585.
- ↑ Habif TP 2010. Hair diseases. In Clinical dermatology, 5th ed Mosby, Maryland Heights, MO [Google Scholar]
- ↑ Otberg N, Shapiro J 2012. Hair growth disorders. In Fitzpatrick’s dermatology in general medicine, 8th ed (ed. Goldsmith LA, et al.). McGraw-Hill, New York [Google Scholar]
- ↑ Otberg N, Shapiro J 2012. Hair growth disorders. In Fitzpatrick’s dermatology in general medicine, 8th ed (ed. Goldsmith LA, et al.). McGraw-Hill, New York [Google Scholar]
- ↑ 20.0 20.1 Callender VD, McMichael AJ, Cohen GF (2004). "Medical and surgical therapies for alopecias in black women". Dermatol Ther. 17 (2): 164–76. doi:10.1111/j.1396-0296.2004.04017.x. PMID 15113284.
- ↑ Aguado Lobo M, Jiménez-Reyes J (2018). dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29265342 "Traction alopecia" Check
|url=
value (help). Int J Dermatol. 57 (2): 231–232. doi:10.1111/ijd.13846. PMID 29265342. - ↑ Sperling LC, Cowper SE, Knopp EA. An atlas of hair pathology with clinical correlations. 2. Informa Healthcare; 2014. [Google Scholar]
- ↑ "StatPearls". 2020. PMID 30725594.
- ↑ Pomeranz AJ, Sabnis SS (2002). "Tinea capitis: epidemiology, diagnosis and management strategies". Paediatr Drugs. 4 (12): 779–83. doi:10.2165/00128072-200204120-00002. PMID 12431130.
- ↑ Kos L, Conlon J (2009). "An update on alopecia areata". Curr Opin Pediatr. 21 (4): 475–80. doi:10.1097/MOP.0b013e32832db986. PMID 19502982.
- ↑ Sperling LC, Cowper SE, Knopp EA. An atlas of hair pathology with clinical correlations. 2. Informa Healthcare; 2014. [Google Scholar]
- ↑ Ponka D, Baddar F (2012). "Wood lamp examination". Can Fam Physician. 58 (9): 976. PMC 3440273. PMID 22972730.
- ↑ Watras MM, Patel JP, Arya R (2016). "Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature". Drugs Real World Outcomes. 3 (1): 1–6. doi:10.1007/s40801-015-0056-z. PMC 4819463. PMID 27747798.
- ↑ Thomson SR, Mamulpet V, Adiga S (2017). "Sodium Valproate Induced Alopecia: A Case Series". J Clin Diagn Res. 11 (9): FR01–FR02. doi:10.7860/JCDR/2017/28564.10658. PMC 5713753. PMID 29207731.
- ↑ HOLOWACH J, SANDEN HV (1960). "Alopecia as a side effect of treatment of epilepsy with trimethadione. Report of two cases". N Engl J Med. 263: 1187. doi:10.1056/NEJM196012082632308. PMID 13715510.
- ↑ Shelley ED, Shelley WB (1985). "Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol". Cutis. 35 (2): 148–9. PMID 3979099.
- ↑ Forouzan P, Cohen PR (2000). "Systemic Lupus Erythematosus Presenting as Alopecia Areata" Check
|url=
value (help). Lancet. 355 (9197): 53–7. doi:10.1016/S0140-6736(99)05157-0. PMID 10615903. - ↑ Callen JP. "Dermatwww.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10615903".